Navigation Links
Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
Date:7/24/2008

New JIT Enrollment Program Speeds Oncology Patient Accrual

DENVER, July 24 /PRNewswire/ -- Pharmatech, Inc., a Research Management Organization (RMO), has contracted with five leading pharmaceutical companies to provide research and site management services for their clinical trials using the Just-in-Time (JIT) enrollment strategy. The new trials include the following disease indications: follicular Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Metastatic Sarcoma, Chronic Myelogenous Leukemia, and Non-Small Cell Lung Cancer (NSCLC).

Pharmatech will manage the trials using its innovative JIT approach. This streamlined approach was created to increase enrollment in oncology clinical trials. This patient first initiative allows for identification of cancer patients through basic standard of care procedures, so the site opens only if the patient qualifies for the study. Patient enrollment increases because a protocol is rolled out to a large number of qualified Research Network sites with minimal expense of time and capital for both the sites and sponsors.

The new oncology clinical trials are targeted to achieve enrollment of over 500 cancer patients with the participation of approximately 165 Pharmatech Research Network sites. Matthew Wiener, Pharmatech CEO, states that "The recent activity in new business has been a true testament to the acceptance of the Just-In-Time enrollment strategy. Study sponsors and sites have praised the new enrollment methodology, as cancer patients are treated in a more efficient manner and sponsors see their trials completed in a shorter time frame."

About Pharmatech, Inc.:

Pharmatech, headquartered in Denver, Colorado, is a Research Management Organization (RMO) dedicated to the highest quality of clinical research. Pharmatech provides services of a Site Management Organization (SMO) and a Contract Research Organization (CRO) with a focus in oncology clinical trials. Through an organized
'/>"/>

SOURCE Pharmatech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
2. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
3. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
4. VIRxSYS to Host a Web Conference to Announce Clinical Trial Update
5. New AAHC Toolkit Available to Optimize Clinical Research Administration
6. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
7. Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
8. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
9. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
10. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
11. AFFiRiS: Milestone Reached in Clinical Trial of Alzheimers Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., PRINCETON, N.J., Nov. 9 /PRNewswire-FirstCall/...nagement will present at the Sixth Annual Lazard C...ce will be held at the St Regis Hotel in New York ... Pharmasset,s President and Chief Executive Office...esday, November 18, 2009 at 3:45 PM (ET). ,, To...
(Date:11/9/2009)...F LAKE, N.J., Nov. 9 Par...y announced that it has extended the expiration da...sly announced "Modified Dutch Auction" tender offe... up to $65,000,000 aggregate principal amount, or ...5% Senior Subordinated Convertible Notes due 2010....
(Date:11/9/2009)..., Nov. 9 MISSION Skincare®, t...tar Serena Williams, soccer professional Mia Hamm,... "Active Lifestyle Skincare Destinations" in the b...ons across the country beginning this week. Stocke...ducts, MISSION and CVS/pharmacy have set out to es...
Breaking Medicine Technology:Pharmasset to Present at Lazard Capital Markets Healthcare Conference 2Pharmasset to Present at Lazard Capital Markets Healthcare Conference 3Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 2Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 3People With Huntingtons Report Discrimination 48766 1People With Huntingtons Report Discrimination 48766 2People With Huntingtons Report Discrimination 48766 3Salient Mobility Launches the Text For a Cause 28TM 29 Campaign in Raising Awareness Through Wireless Health Tips 48763 1Salient Mobility Launches the Text For a Cause 28TM 29 Campaign in Raising Awareness Through Wireless Health Tips 48763 2RA individuals from lower GDP countries keep working despite worse symptoms than richer countries 48759 1RA individuals from lower GDP countries keep working despite worse symptoms than richer countries 48759 2
...l phase I trial,AFF001, AFFiRiS GmbH has now recru...ial. The trial aims to investigate the tolerabilit...(AFFITOPE AD01). In the trial, all,patients have n...olerated,the vaccine extremely well. The treatment...nthly intervals and is due to be fully completed b...
...maceuticals, Inc. (Nasdaq: MAPP ) announced that ...ng the safety, tolerability and,pharmacokinetics o...e July,issue of Current Medical Research and Opini...orally inhaled and self-administered therapy, as a...ults, which were first announced last year, demons...
Other Medicine Technology:AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 2AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4
(Date:11/9/2009)... Study in mice reports success with drugs that in...lthDay News) -- Two drugs used to treat breast can... mice, according to a new study. , The drugs al...vagina, and prevented the onset of cancer in mice ...drug fulvestrant and the breast cancer/osteoporosi...
(Date:11/9/2009)... Plavix helped men and women almost equally, stud...News) -- The widely used clot-dissolving drug Plav...in men, an analysis of major clinical trials has f...confident in treating both men and women with this... director of cardiovascular thrombosis at New York...
(Date:11/9/2009)... , Networking is everybod...s it means Money. StaffingClub.com enables Recruit...of contacts to connect, share, communicate and clo... Seekers to post their profiles and network with r...mber 9, 2009 -- Current Job Market forces everyone...
(Date:11/9/2009)... Therapy to improve letter formation could boost ... Nov. 9 (HealthDay News) -- Autistic children are ...g trouble forming letters, than those without auti...8 children, aged 8 to 13. Half of the study partic...e children scored within the normal range for perc...
(Date:11/9/2009)... Rabbits implanted with new cells regained sexual...v. 9 (HealthDay News) -- Researchers were able to ...nises by growing new penile tissue in the lab and ...human application is a ways off, researchers say t... erectile dysfunction in men. , "We were able t...
Breaking Medicine News(10 mins):Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3
...ffected the dental health of the expectant mother....ammations can lead to a condition of preeclampsia ...ic dental inflammation and periodontal infection, ...moking, etc. The basic reason for setting in the d...
...nic, progressive disorder where there is a loss of...rug // alendronate if taken daily for 10 years can...ugs, such as alendronate, have been used for years...he drug for the next two years. Then for the next ...
...that fetal cell transplantation for patients with ...id of their medications altogether.// Parkinso... impairs mobility. Patients with Parkinson’s lack ...st dopamine-producing cells to help restore moveme...
...ommon sleep disorder leaves nearly millions groggy...is that // the tricks they do to get to sleep may ...alists say as we age, biological changes gradually...to do is to cut out caffeine after noon and to ski...
... recent study researchers say annual flu vaccines ... on // hospitalizations, respiratory tract infecti...pecially true for children who received an inactiv...r children under age 2 who received the inactivate...
...Society's 140th Midwinter Meeting that begins in U...orld over can take a peek to some very innovative ...isplay there. The convention is also one of the la...s that automatically dispenses toothpaste, and a c...
Other Medicine News:
Castroviejo Suture Forceps
deJuan Pic Forceps - Black
Thomas Long Subretinal Forceps
Olk Membrane Peeler
Medicine Products: